Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Vogenx Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Vogenx Inc. market cap is $195.93M.
What is the 52-week high for Vogenx Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vogenx Inc. 52 week high is $14.20 as of August 14, 2026.
What is the 52-week low for Vogenx Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vogenx Inc. 52 week low is $12.95 as of August 14, 2026.
What is Vogenx Inc. stock price today?
Vogenx Inc. stock price today is $14.09.
What was Vogenx Inc. stock price yesterday?
Vogenx Inc. stock price yesterday was $13.00.
What is the Price-to-Book ratio of Vogenx Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Vogenx Inc. P/B ratio is -140.0596.
What is the 50-day moving average of Vogenx Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Vogenx Inc. 50-day moving average is $13.36.